GSK says antibody drug 'Sotrovimab' works against Omicron https://ift.tt/eA8V8J

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 has indicated that the drug also works against the new Omicron variant. Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/31lE386
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.